TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP (TCBIO) Stock Analyst Ratings

NASDAQ:TCBIO • US88224Q3056

22.36 USD
+0.07 (+0.31%)
At close: Feb 27, 2026
22.4 USD
+0.04 (+0.18%)
After Hours: 2/27/2026, 4:30:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

69

ChartMill assigns a Buy % Consensus number of 69% to TCBIO. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 22.17. This target is -0.85% below the current price.
  • TCBIO was analyzed by 19 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about TCBIO.
  • In the previous month the buy percentage consensus was at a similar level.
  • TCBIO was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
TCBIO Historical Analyst RatingsTCBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 22.3618.2822.9722.1724.84 - -18.24% 2.75% -0.85% 11.08%

Related screens

Find peers 30% below price target
TCBIO Current Analyst RatingTCBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades

TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP / TCBIO FAQ

What do analysts expect the price target to be for TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP (TCBIO)?

19 analysts have analysed TCBIO and the average price target is 22.17 USD. This implies a price decrease of -0.85% is expected in the next year compared to the current price of 22.36.


How do analysts rate TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP (TCBIO)?

The consensus rating for TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP (TCBIO) is 69.4737 / 100 . This indicates that analysts generally have a neutral outlook on the stock.